Prevalence of antimicrobial resistant pathogens from blood cultures from Canadian hospitals: results of the CANWARD 2007-2009 study

被引:31
作者
Adam, Heather J. [1 ,2 ]
DeCorby, Melanie [2 ]
Rennie, Robert [3 ]
Karlowsky, James A. [1 ,2 ]
Hoban, Daryl J. [1 ,2 ]
Zhanel, George G. [2 ]
机构
[1] Hlth Sci Ctr, Dept Microbiol, Diagnost Serv Manitoba, Winnipeg, MB R3A 1R9, Canada
[2] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB R3E 0J9, Canada
[3] Univ Alberta Hosp, Dept Lab Med & Pathol, Edmonton, AB T6G 2B7, Canada
关键词
Bacteremia; Resistance; Hospitals; INTENSIVE-CARE-UNIT; STREAM INFECTION; BACTEREMIA; SUSCEPTIBILITY;
D O I
10.1016/j.diagmicrobio.2010.10.026
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This study assessed the epidemiology and antimicrobial resistance of pathogens associated with bloodstream infections in Canadian hospitals between 2007 and 2009. Tertiary-care medical centers representing 8 of 10 Canadian provinces submitted bloodstream infection pathogens from patients attending hospital clinics, emergency rooms, medical/surgical wards, and intensive care units. Over 8,000 blood culture pathogens were collected. The 10 most common pathogens (representing 80.9% of all isolates) were Escherichia coli ( I 856 [22.6%]), Staphylococcus aureus (1457 [17.7%] including 1101 methicillin-susceptible Staphylococcus aureus and 356 methicillin-resistant Staphylococcus aureus), coagulase-negative staphylococci (907 [11.0%]), Klebsiella pneumoniae (600 [7.3%]), Streptococcus pneumoniae (470 [5.7%]), Enterococcus faecalis (360 [4.4%]), Pseudomonas aeruginosa (333 [4.0%]), viridans group streptococci (321 [3.9%]), Enterobacter cloacae (193 [2.3%]), and Streptococcus pyogenes (159 [1.9%]). The most active agents against Gram-negative bacilli were carbapenems (e.g., meropenem and ertapenem) and piperacillin-tazobactam, while for Gram-positive cocci, they were vancomycin, linezolid, and daptomycin. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:307 / 313
页数:7
相关论文
共 16 条
  • [1] [Anonymous], 2010, CLSI Document M100-S20
  • [2] Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002)
    Biedenbach, DJ
    Moet, GJ
    Jones, RN
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2004, 50 (01) : 59 - 69
  • [3] *CLSI, 2006, M27S2 CLSI
  • [4] *CLSI, 2009, M78 CLSI
  • [5] CLSI, 2008, CLSI standard M27-3rd
  • [6] DECOUSSER JW, 2009, DIAGN MICROBIOL INFE, V66, P292
  • [7] Nosocomial bacteremia: Clinical significance of a single blood culture positive for coagulase-negative staphylococci
    Favre, B
    Hugonnet, S
    Correa, L
    Sax, H
    Rohner, P
    Pittet, D
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2005, 26 (08) : 697 - 702
  • [8] Introduction to the CANWARD Study (2007-2009)
    Hoban, Daryl J.
    Zhanel, George G.
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2011, 69 (03) : 289 - 290
  • [9] Detection and treatment of bloodstream infection: Laboratory reporting and antimicrobial management
    Munson, EL
    Diekema, DJ
    Beekmann, SE
    Chapin, KC
    Doern, GV
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (01) : 495 - 497
  • [10] Guidelines for treatment of candidiasis
    Pappas, PG
    Rex, JH
    Sobel, JD
    Filler, SG
    Dismukes, WE
    Walsh, TJ
    Edwards, JE
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 38 (02) : 161 - 189